Literature DB >> 3871949

Isolation and biochemical characterization of the mammalian reovirus type 3 cell-surface receptor.

M S Co, G N Gaulton, B N Fields, M I Greene.   

Abstract

A cell-surface receptor for the mammalian reovirus type 3 hemagglutinin was isolated by using antiidiotypic anti-receptor antibodies. The receptor is a glycoprotein with a molecular mass of 67,000 daltons and a pI of 5.9. Evidence that the isolated structure represents the reovirus receptor was obtained by electrophoretic immunoblot studies, which demonstrated that the 67,000-dalton glycoprotein is the only cell-surface structure recognized by both reovirus type 3 and the anti-receptor immunoglobulin. Comparison of the reovirus receptor on murine thymoma (R1.1) and rat neuroblastoma (B104) cells indicated that similar structures on the cell surface are recognized by the reovirus type 3 and the anti-receptor antibodies as previously suggested from cellular and binding studies. This receptor was found on mouse, rat, monkey, and human cells. Furthermore, diverse tissue types, including lymphoid and neuronal cells, express the receptor structure. The receptor structure is discussed in terms of its role in mediating viral tropism and as an essential cell-surface protein.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3871949      PMCID: PMC397289          DOI: 10.1073/pnas.82.5.1494

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  35 in total

1.  Continuous cultures of fused cells secreting antibody of predefined specificity.

Authors:  G Köhler; C Milstein
Journal:  Nature       Date:  1975-08-07       Impact factor: 49.962

2.  High resolution two-dimensional electrophoresis of proteins.

Authors:  P H O'Farrell
Journal:  J Biol Chem       Date:  1975-05-25       Impact factor: 5.157

3.  Molecular basis of reovirus virulence: role of the S1 gene.

Authors:  H L Weiner; D Drayna; D R Averill; B N Fields
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

4.  "Panning" for lymphocytes: a method for cell selection.

Authors:  L J Wysocki; V L Sato
Journal:  Proc Natl Acad Sci U S A       Date:  1978-06       Impact factor: 11.205

5.  Hydrocephalus in hamsters, ferrets, rats, and mice following inoculations with reovirus type I. I. Virologic studies.

Authors:  L Kilham; G Margolis
Journal:  Lab Invest       Date:  1969-09       Impact factor: 5.662

6.  Reovirus type 3 encephalitis: observations of virus-cell interactions in neural tissues. I. Light microscopy studies.

Authors:  G Margolis; L Kilham; N K Gonatas
Journal:  Lab Invest       Date:  1971-02       Impact factor: 5.662

7.  Identification of the gene coding for the hemagglutinin of reovirus.

Authors:  H L Weiner; R F Ramig; T A Mustoe; B N Fields
Journal:  Virology       Date:  1978-05-15       Impact factor: 3.616

8.  Use of anti-idiotypic antibodies as cell-surface receptor probes.

Authors:  K Sege; P A Peterson
Journal:  Proc Natl Acad Sci U S A       Date:  1978-05       Impact factor: 11.205

9.  A genetic map of reovirus. II. Assignment of the double-stranded RNA-negative mutant groups C, D, and E to genome segments.

Authors:  R F Ramig; T A Mustoe; A H Sharpe; B N Fields
Journal:  Virology       Date:  1978-04       Impact factor: 3.616

10.  Syngeneic monoclonal antiidiotype can induce cellular immunity to reovirus.

Authors:  A H Sharpe; G N Gaulton; K K McDade; B N Fields; M I Greene
Journal:  J Exp Med       Date:  1984-10-01       Impact factor: 14.307

View more
  40 in total

1.  Identification of cell surface receptors for the 86-kilodalton glycoprotein of human cytomegalovirus.

Authors:  S Keay; T C Merigan; L Rasmussen
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

2.  Interaction of recombinant norwalk virus particles with the 105-kilodalton cellular binding protein, a candidate receptor molecule for virus attachment.

Authors:  M Tamura; K Natori; M Kobayashi; T Miyamura; N Takeda
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

3.  Binding of type 3 reovirus by a domain of the sigma 1 protein important for hemagglutination leads to infection of murine erythroleukemia cells.

Authors:  D H Rubin; J D Wetzel; W V Williams; J A Cohen; C Dworkin; T S Dermody
Journal:  J Clin Invest       Date:  1992-12       Impact factor: 14.808

4.  Anti-reovirus receptor antibody accelerates expression of the optic nerve oligodendrocyte developmental program.

Authors:  J A Cohen; W V Williams; H M Geller; M I Greene
Journal:  Proc Natl Acad Sci U S A       Date:  1991-02-15       Impact factor: 11.205

5.  Use of a lambda gt11 expression library to localize a neutralizing antibody-binding site in glycoprotein E2 of Sindbis virus.

Authors:  K S Wang; J H Strauss
Journal:  J Virol       Date:  1991-12       Impact factor: 5.103

6.  Identification of antigenically important domains in the glycoproteins of Sindbis virus by analysis of antibody escape variants.

Authors:  E G Strauss; D S Stec; A L Schmaljohn; J H Strauss
Journal:  J Virol       Date:  1991-09       Impact factor: 5.103

Review 7.  Strategies for the identification of icosahedral virus receptors.

Authors:  D M Bass; H B Greenberg
Journal:  J Clin Invest       Date:  1992-01       Impact factor: 14.808

8.  Nucleic acid sequence of an internal image-bearing monoclonal anti-idiotype and its comparison to the sequence of the external antigen.

Authors:  C Bruck; M S Co; M Slaoui; G N Gaulton; T Smith; B N Fields; J I Mullins; M I Greene
Journal:  Proc Natl Acad Sci U S A       Date:  1986-09       Impact factor: 11.205

9.  Reovirus type 3 and [125I]-iodocyanopindolol bind to distinct domains on the beta-adrenergic like receptor.

Authors:  J Liu; M S Co; M I Greene
Journal:  Immunol Res       Date:  1988       Impact factor: 2.829

10.  Effect of neuraminidase treatment of cells and effect of soluble glycoproteins on type 3 reovirus attachment to murine L cells.

Authors:  J R Gentsch; A F Pacitti
Journal:  J Virol       Date:  1985-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.